Photodynamic therapy: Promotion of efficacy by a sequential protocol
Author:
Open Access
- 1 January 2016
- journal article
- research article
- Published by World Scientific Pub Co Pte Ltd in Journal of Porphyrins and Phthalocyanines
- Vol. 20 (01n04) , 302-306
Abstract
Photodynamic therapy (PDT) offers a new approach to selective tumor eradication. Modifications designed to increase and optimize efficacy continue to emerge. Selective photodamage to malignant cells and their environment can bring about tumor cell destruction, shutdown of the tumor vasculature, stimulation of immunologic anti-tumor effects and potentiation of other therapeutic effects. Current development of combination protocols may provide a better rationale for integration of PDT into clinical practice. An example described here is the ability of a sequential (two-sensitizer) PDT protocol to enhance the efficacy of photokilling. The first step involves low-level lysosomal photodamage that has been shown to promote the apoptotic response to subsequent photodynamic effects directed at mitochondria. In this report, we demonstrate the ability of Photofrin, an FDA-approved photosensitizing agent, to serve as either the first or second element of the sequential protocol.Keywords
This publication has 31 references indexed in Scilit:
- Development of photodynamic therapy regimens that control primary tumor growth and inhibit secondary diseaseCancer Immunology, Immunotherapy, 2014
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Cancer vaccines generated by photodynamic therapyPhotochemical & Photobiological Sciences, 2011
- Photo-oxidation of cardiolipin and cytochrome c with bilayer-embedded Pc 4Free Radical Biology and Medicine, 2010
- PDT‐associated host response and its role in the therapy outcomeLasers in Surgery and Medicine, 2006
- The Hydra Phenomenon of Cancer: Why Tumors Recur Locally after Microscopically Complete ResectionCancer Research, 2005
- Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavageCell Death & Differentiation, 2002
- Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4Oncogene, 2001
- Photodynamic TherapyJNCI: Journal of the National Cancer Institute, 1998
- Rapid Initiation of Apoptosis by Photodynamic TherapyPhotochemistry and Photobiology, 1996